Name: Torrent Pharmaceuticals Ltd. Financial Filings and Reports
Creator: FinancialReports
License: https://financialreports.eu/terms/

Filings indexed 1,762 across all filing types

Latest filing 2024-01-30 Regulatory Filings

Country IN India

Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing	Released	Lang
Intimation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-01-30	English
Updates Regulatory Filings	2024-01-30	English
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mehta Family Trust 1 & Others & PACs Regulatory Filings	2024-01-30	English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mehta Family Trust 1 & Others & PACs Regulatory Filings	2024-01-30	English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mehta Family Trust & PACs Regulatory Filings	2024-01-24	English
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mehta Family Trust & PACs Regulatory Filings	2024-01-24	English

Browse filings by year

17 years

	ID	Filing	Released	Lang
2024 15 filings
	45815381	Intimation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-01-30	English
	42696546	Updates Regulatory Filings	2024-01-30	English
	45815377	The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mehta Family Trust 1 & Others & PACs Regulatory Filings	2024-01-30	English
	45815410	The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mehta Family Trust 1 & Others & PACs Regulatory Filings	2024-01-30	English
	45815421	The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mehta Family Trust & PACs Regulatory Filings	2024-01-24	English
	45815453	The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mehta Family Trust & PACs Regulatory Filings	2024-01-24	English
	45815402	Post Quarterly Financial Result Conference call with investors / analyst Regulatory Filings	2024-01-22	English
	42700750	Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-01-22	English
	42704635	Updates Regulatory Filings	2024-01-20	English
	45815468	Intimation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-01-20	English
	42690659	Updates Regulatory Filings	2024-01-13	English
	45815429	Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-01-13	English
	45815436	Intimation of Record Date pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Notice of Dividend Amount	2024-01-12	English
	43989533	Board Meeting — TORRENT PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 02-Feb-2024 to consider and approve the Quarterly Unaudited Financial results of the Compan… Regulatory Filings	2024-01-12	English
	43989523	Board Meeting — Financial Results/Dividend/Other business matters Regulatory Filings	2024-01-12	English

Page 38 of 118

Prev … 36 37 38 39 40 … Next

Market data

Market data not available

Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products

2,202 peers

Company	Ticker	Country	Sector
13260917 Canada Inc. Biotech developing oral small molecules to restore muscle s…	MSCL	CA	Manufacturing
1608557 Ontario Inc. Biopharmaceutical company dedicated to R&D, discovery, and …	OTROQ	CA	Manufacturing
3B BlackBio Dx Limited Develops molecular diagnostic kits for oncology, infectious…	3BBLACKBIO	IN	Manufacturing
3D Medicines Inc. Commercial-stage biopharma specializing in next-generation …	1244	HK	Manufacturing
3SBio Inc. Biopharmaceutical enterprise specializing in R&D, productio…	1530	KY	Manufacturing
4BASEBIO PLC Manufactures GMP-grade synthetic DNA for next-generation th…	4BB	GB	Manufacturing
4D Molecular Therapeutics, Inc. Develops genetic medicines using AAV vectors for ophthalmol…	FDMT	US	Manufacturing
4Front Ventures Corp. Vertically integrated cannabis operator managing cultivatio…	FFNT	CA	Manufacturing
4SC AG Biopharmaceutical company with no products under developmen…	VSC	DE	Manufacturing
60 DEGREES PHARMACEUTICALS, INC. Develops and commercializes medicines for infectious diseas…	SXTP	US	Manufacturing

Page 1 of 221

1 2 3 … Next

Torrent Pharmaceuticals Ltd. via the API

Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.

Get API access Read API reference

Base URLapi.financialreports.eu

Auth headerx-api-key

Company ID61979

TickerTORNTPHARM

ISININE685A01028

Endpoints

most-used routes for this company

GET	/api/companies/61979/	Company identity, sector, listing, identifiers
GET	/api/filings/?company=61979	Paginated list of all filings (filterable by type, date, language)
GET	/api/filings/{id}/	Single filing — metadata, document URL, processing status
GET	/api/filings/{id}/markdown/	Filing content as Markdown (PDF → text/tables/figures)
GET	/api/isins/?company=61979	All ISINs registered to this company
GET	/api/filing-types/	Reference: every filing-type code + category

Full reference: API reference · OpenAPI schema

cURL

latest filings for Torrent Pharmaceuticals Ltd.

$ curl https://api.financialreports.eu/api/filings/?company=61979 \
    -H "x-api-key: $FR_API_KEY" \
    -H "Accept: application/json"

Python

requests

import requests

r = requests.get(
    "https://api.financialreports.eu/api/filings/",
    params={"company": 61979},
    headers={"x-api-key": API_KEY},
)
filings = r.json()["results"]

MCP server

Claude · Claude Code · ChatGPT

Claude setup ChatGPT setup Claude Code setup

// MCP server URL
https://mcp.financialfilings.com/mcp

// Once connected, the LLM can query this company directly:
"Pull the latest 5 filings for Torrent Pharmaceuticals Ltd. (id: 61979)"

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings